Concepedia
Statistics
Publications
12
Citations
276
H-Index
11
Active since
2019
Affiliations
Gdańsk Medical University(Current)
Seoul National University Hospital
Catholic University of Korea
Hospital Universitario Quirónsalud Madrid
Regeneron (United States)
Michał Taszner is an author at Gdańsk Medical University specializing in oncology, immunotherapy, and medicine.
Publications per year
2019–2025
Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma
Tae Min Kim, Michał Taszner, Silvana Novelli et al. · Annals of Oncology · 2024 · 76 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
Won Seog Kim, Tae Min Kim, Seok‐Goo Cho et al. · Nature Cancer · 2025 · 44 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +17
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
Anna Felberg, Michał Taszner, A Urban et al. · Frontiers in Immunology · 2020 · 24 citations · Full text
Life Sciences, Immunology, Oncology +17
Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma
Adam J. Olszewski, Herbert Eradat, Abraham Avigdor et al. · Blood · 2023 · 23 citations
Medicine, Geriatric Medicine, Oncology +8
Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2
Tae Min Kim, Michał Taszner, Seok‐Goo Cho et al. · Blood · 2022 · 20 citations
Medicine, Oncology, Pharmacotherapy +10
1–5 of 12